Scopus BioPharma Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2020 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Scopus BioPharma Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q1 2023.
- Scopus BioPharma Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$760K, a 80.9% increase year-over-year.
- Scopus BioPharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$8.13M, a 28.9% increase from 2021.
- Scopus BioPharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$11.4M, a 352% decline from 2020.
- Scopus BioPharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$2.53M, a 19.1% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)